Φορτώνει......
Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
The majority of monoclonal antibody (mAb) therapeutics possess the ability to engage innate immune effectors through interactions mediated by their fragment crystallizable (Fc) domain. By delivering Fc-Fc gamma receptor (FcγR) and Fc-C1q interactions, mAb are able to link exquisite specificity to po...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Antibodies (Basel) |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709126/ https://ncbi.nlm.nih.gov/pubmed/33212886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib9040064 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|